Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

Tagged on-sale bar · clear

THE MEDICINES COMPANY v. HOSPIRA, INC.

Federal Circuit Summary Before Dyk, Wallach, and Hughes . Appeal from the United States District Court for the District of Delaware. Summary : A distribution agreement qualifies as an invalidating “offer for sale” under 35 U.S.C. § 102(b)…

February 6, 2018Federal Circuit2 min read

Federal Circuit

In Helsinn Healthcare, the Federal Circuit Offers Guidance on the On-Sale Bar under the AIA

Written by Scott Siera, Ph.D . and Eric Furman, Ph.D. The sale of a product prior to filing a patent application, or “on-sale bar,” has long been a potential barrier to obtaining a patent in the United States. Especially in the biotechnology…

May 4, 2017Federal Circuit3 min read